OraQuick(R) Launches "Make Knowing Your Thing Today" Campaign to Promote the Importance of Knowing Your HIV Status
25 3월 2013 - 7:00PM
OraSure Technologies, Inc. (Nasdaq:OSUR), maker of the OraQuick®
In-Home HIV Test, announced today the launch of a nationwide
awareness campaign to encourage everyone to learn their HIV status.
The campaign, "Make Knowing Your Thing Today" asks people across
the country to share their story about their decision to test for
HIV. The awareness campaign is part of an integrated national
marketing program that includes events, as well as national and
local radio, outdoor advertising, television, print and digital
advertising.
Earvin "Magic" Johnson has teamed with OraSure to kick off this
campaign today, sharing his story of knowing, and encouraging
others to do the same.
"Knowing your HIV status is important, but that doesn't mean
that the decision to get tested is easy. Everyone follows a
different path to testing and everyone has different reasons for
doing it," said Earvin "Magic" Johnson, CEO of Magic Johnson
Enterprises. "We need to have an open and honest dialogue about
HIV/AIDS to help remove the stigma around testing, so more people
get tested. The more people we get to join the conversation, the
more powerful the message will be: Testing for HIV/AIDS can save
lives. It's everyone's thing."
The OraQuick® In-Home HIV Test is the first ever in-home rapid
infectious disease test made available directly to consumers.
Launched in October 2012, the test detects antibodies to both HIV-1
and HIV-2 with an oral swab, providing a confidential in-home
testing option with results in as little as 20 minutes. It is
available in most national drugstore and mass merchandiser retail
outlets nationwide and online at OraQuick.com.
OraQuick® has launched the "Make Knowing Your Thing Today"
campaign to encourage people to take the important step towards
learning their HIV status. The campaign features a contest, which
asks participants to submit a short video or photo with caption at
www.OraQuick.com/knowing, to share their story about why they
decided to get tested for HIV. A winning entry will be selected
based on viewer voting and input from a panel of judges. The winner
will be a part of a future OraQuick® In-Home HIV Test promotion.
The contest runs through July 2013.
"HIV/AIDS continues to be one of the most significant health
crises facing America today. Knowing your HIV status is the best
thing for everyone, regardless of age, race or sexual orientation,"
said Douglas A. Michels, President and Chief Executive Officer of
OraSure Technologies. "It has never been easier than now with our
OraQuick® In-Home HIV Test, which empowers people to test in the
comfort and privacy of their own home."
According to the Centers for Disease Control and Prevention
(CDC), there are approximately 1.2 million people in the U.S. that
have HIV and approximately 240,000 of them are unaware of their
status. Those who do not know they are HIV positive are
disproportionately responsible for the 50,000 new HIV infections
that occur each year.
Approved by the U.S. Food and Drug Administration (FDA) in July
2012, the OraQuick® In-Home HIV Test was named one of the "Best
Inventions of 2012" by TIME and was also named a "Top Health
Breakthrough of 2012" by Men's Health magazine. It is an
over-the-counter version of OraQuick ADVANCE®, an oral swab rapid
test with more than 25 million units sold in the professional
market, including doctors, hospitals, clinics and other trained
professionals.
To ensure optimal support for individuals using the OraQuick®
In-Home HIV Test, OraSure offers live support and comprehensive
referral services 24 hours a day, seven days a week, every day of
the year, through a toll-free support center and comprehensive
consumer website at www.oraquick.com. The OraQuick® Support Center
is staffed with highly trained, bi-lingual (English/Spanish)
representatives who are available by telephone at 866-436-6527 to
answer questions about HIV/AIDS and using and interpreting the
test. They also provide referrals to follow-up and care, and can
take orders for the OraQuick In-Home HIV Test. Additionally, the
product website provides access to resources and referral to
follow-up counseling, confirmatory testing and medical care.
For more information on the "Make Knowing Your Thing Today"
campaign and video contest, visit www.OraQuick.com/knowing.
About OraSure Technologies
OraSure Technologies is a leader in the development, manufacture
and distribution of oral fluid diagnostic and collection devices
and other technologies designed to detect or diagnose critical
medical conditions. Its innovative products include rapid tests for
the detection of antibodies to HIV and HCV at the point of care and
testing solutions for detecting various drugs of abuse. In July
2012, the Company received approval from the U.S. Food and Drug
Administration for the Company's OraQuick® In-Home HIV Test for
sale directly to consumers in the over-the-counter (OTC) market -
making it the first and only rapid OTC HIV test approved in the
U.S. In addition, the Company is a leading provider of oral fluid
sample collection, stabilization and preparation products for
molecular diagnostic applications. OraSure's portfolio of products
is sold globally to various clinical laboratories, hospitals,
clinics, community-based organizations and other public health
organizations, research and academic institutions, distributors,
government agencies, physicians' offices, and commercial and
industrial entities. The Company's products enable healthcare
providers to deliver critical information to patients, empowering
them to make decisions to improve and protect their health.
For more information on OraSure Technologies, please visit
www.orasure.com.
CONTACT: Media Contact:
Jennifer Moritz
Zer0 to 5ive for OraSure Technologies
917-748-4006
jmoritz@0to5.com
OraSure Technologies (NASDAQ:OSUR)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
OraSure Technologies (NASDAQ:OSUR)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024